Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE
The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "009:25" ] |
| contactPoint |
{ "fn": "NIH/NCBI Data Team", "@type": "vcard:Contact", "hasEmail": "mailto:info@ncbi.nlm.nih.gov" } |
| description | The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Official Data Source", "mediaType": "text/html", "description": "Access the complete Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400287-T1" } ] |
| identifier | https://healthdata.gov/api/views/2ddn-smki |
| issued | 2025-09-05 |
| keyword |
[ "chemistry", "innovation", "patent", "pubchem", "research" ] |
| landingPage | https://healthdata.gov/d/2ddn-smki |
| modified | 2025-09-06 |
| programCode |
[ "009:066" ] |
| publisher |
{ "name": "National Center for Biotechnology Information (NCBI)", "@type": "org:Organization" } |
| theme |
[ "NIH" ] |
| title | Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE |
